Dr. Melinda Cail from Primary Health Partners joins us in the KFOR Studios on Thursday afternoon to discuss Parkinson's disease.

The Phase I trial of ENERGI-F705PD tablet was a randomized, double-blind, placebo-controlled study designed to evaluate the safety, tolerability, and ...

Neu Health, a newly released phone app cleared by the FDA this week could help measure early, tell-tale signs of a growing ...

It was the early 2000s when researchers first showed that exercise can help relieve the tremors that are common with ...

The dogs were trained to distinguish between the oily skin secretions – or sebum – of people with Parkinson’s from those ...

Long-term cycling programs appear to reshape brain signals in Parkinson’s patients Deep brain stimulation recordings reveal ...

Black Sabbath frontman Ozzy Osbourne died following his battle with a genetic form of Parkinson's disease, while a brain ...

Detecting early rising Parkinson's disease (PD) symptoms could improve treatment outcomes by enabling earlier treatment ...

Osbourne was impacted by a gene called PARK 2, which is also known as PRKN-2. When the gene is mutated, it is the most common ...

Heavy metal rocker Ozzy Osbourne died July 22 at the age of 76, just weeks after his farewell show and about five years after ...

An early-stage clinical trial in France appeared to help restore some brain function for three Parkinson's patients. View on ...

Congruence secures a $5 million grant to advance innovative therapies for GBA1 Parkinson's disease, enhancing hope for ...